Post by Tony Crispino on Feb 10, 2014 12:10:07 GMT -8
Just a share from ASCO:
jco.ascopubs.org/content/32/5/376?cmpid=jco_etoc_10February2014
Filed under “Comments and Controversies” this article is about the difficulty of doing cancer research trials.
Here’s aline I thought interesting:
"As a result of the increasing regulatory requirements and the need for CRO involvement, the cost of research per patient on a phase IIIA oncology trial has ballooned from an average of $3,000 to $5,000 in the early 1990s to a range of $75,000 to $125,000 in 2013. In just 3 years (from 2008 to 2011), per-patient clinical trial costs increased by 70%, without reassurance that we are obtaining proportionately more quality for those research dollars.7”
Tony
jco.ascopubs.org/content/32/5/376?cmpid=jco_etoc_10February2014
Filed under “Comments and Controversies” this article is about the difficulty of doing cancer research trials.
Here’s aline I thought interesting:
"As a result of the increasing regulatory requirements and the need for CRO involvement, the cost of research per patient on a phase IIIA oncology trial has ballooned from an average of $3,000 to $5,000 in the early 1990s to a range of $75,000 to $125,000 in 2013. In just 3 years (from 2008 to 2011), per-patient clinical trial costs increased by 70%, without reassurance that we are obtaining proportionately more quality for those research dollars.7”
Tony